细菌性肺炎通过肺微生物群-免疫轴改变呼吸道微生物群和炎症概况
Xiaoyi Ye1, Binghan Shen2, Zhiming Cai2
1Department of Respiratory and Critical Care Medicine, Quanzhou First Hospital Affiliated to Fujian Medical University, 252# East Street, Licheng District, Quanzhou, 362000, Fujian, China. y2841966370@163.com.
细菌性肺炎会改变肺部微生物组和炎症反应. 治疗恢复了微生物多样性,并减少了关键的炎症标志物,这表明肺微生物和免疫轴的破坏.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 细菌性肺炎是一个重大的公共卫生问题,往往导致滥用和抗生素耐药性.
- 了解呼吸道微生物群与宿主免疫之间的相互作用对于有效治疗至关重要.
研究的目的:
- 在治疗前和治疗后,研究细菌性肺炎患者呼吸道微生物组和炎症概况的变化.
- 将这些变化与健康对照进行比较,并确定潜在的治疗点.
主要方法:
- 来自细菌性肺炎患者和健康对照者的支气管洗液 (BALF) 和血清的分析.
- 使用ELISA进行微生物组概况 (多样性和生物标志物) 和炎症性细胞因子 (TNF-α,IL-6) 的测量.
- 微生物属和细胞因子之间的相关性分析.
主要成果:
- 与接受治疗的患者和对照人群相比,患有细菌性肺炎的患者表现出白细胞数量的改变和微生物多样性的减少.
- 在所有组中观察到α和β多样性的显著差异.
- 治疗导致TNF-α和IL-6水平降低,在特定细菌属和炎症标志物之间发现了相关性.
结论:
- 细菌性肺炎会破坏呼吸道微生物群,并通过肺微生物群-免疫轴主导炎症反应.
- 这些干扰有助于免疫失调,突出了针对性治疗策略的必要性.
更多相关视频
06:43Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
相关概念视频
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
